Effect of Dioscorea villosa extract and the phytoestrogen diosgenin on ovariectomized mice with zymosan-induced arthritis

Abstract Humans are exposed to natural compounds such as phytoestrogens primarily through diet and supplements. These compounds promote health by alleviating the symptoms and illnesses associated with menopause and arthritis. Diosgenin (DSG) occurs naturally in plants such as Dioscorea villosa (DV) and binds to estrogen receptors, so it may have similar effects to this hormone, including against arthritis. Thus, we investigated the effect of chronic treatment with dry extract of DV and its phytoestrogen DSG on ovariectomized mice with arthritis. We found that dry extract of Dioscorea villosa (DV) contains the phytoestrogen diosgenin (DSG) in its composition. Furthermore, arthritic mice treated with DV and DSG showed reduced neutrophil accumulation in the articular cartilage. Also, the dry extract of DV administered orally (v.o) did not alter the leukocyte count in the joints or promote changes in the reproductive tract. However, DSG altered these parameters, with possible beneficial effects by reducing symptoms related to reproductive aging. Thus, oral treatment with dry extract of DV and subcutaneous (s.c) treatment with DSG showed promise by acting against inflammation caused by arthritis and reducing symptoms in the reproductive tract due to menopause.

Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy

ABSTRACT Introduction Instruments to manage adverse effects of endocrine therapy with Aromatase inhibitors (AI) may improve adherence and persistence to treatment and Health-Related Quality of Life (HRQL). The 31-item Cervantes Scale (CS-31) is an HRQL questionnaire with particularities of the perimenopausal and postmenopausal period that could be an appropriate instrument to assess HRQL in Breast Cancer (BC) survivors. Objective This study aimed to perform additional validation of the CS-31 for BC survivors undergoing adjuvant endocrine therapy. Methods This prospective study was performed at three time points named T0, T1, and T2: initial, intermediate, and final follow-up period, respectively, totaling 24 months of follow-up. At each time point, the participants completed the CS-31, Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F), and Hospital Anxiety and Depression Scale (HADS). The internal consistency, construct validity, responsiveness analyses, and known-group validity of CS-31 were evaluated. Results This study included 89 postmenopausal women diagnosed with hormone receptor-positive early BC in adjuvant endocrine therapy with AI. The internal consistency was good (Cronbach's alpha = 0.89). Construct validity received a positive rating, with 100% of results consistent with prior hypotheses. A prospective improvement in HRQL was identified for the CS-31 Global Score and FACIT-F Total Score and for most of their domains. Furthermore, women with anxiety and depression by HADS presented worse HRQL by CS-31. Conclusion The authors identified that the CS-31 seems to be appropriate for use in oncology medical routine and may help to monitor adverse effects and HRQL of BC survivors during adjuvant endocrine therapy.

The effect of music on menopausal symptoms, sleep quality,and depression: a randomized controlled trial

SUMMARY OBJECTIVE: This study aimed to determine the effect of music on menopausal symptoms, sleep quality, and depression levels in menopausal women. METHODS: This randomized controlled study was carried out between August and December 2022. The study sample consisted of 61 menopausal women (intervention: 30 and control: 31). The intervention group listened to music twice a day for 5 weeks, with a total of 70 sessions. The control group received only routine care. Menopause symptoms, depression levels, and sleep quality were evaluated at the beginning and the end of the study using the Menopausal Symptoms Rating Scale, Beck Depression Inventory, and Pittsburg Sleep Quality Index. RESULTS: The post-test Menopausal Symptoms Rating Scale, Beck Depression Inventory, and Pittsburg Sleep Quality Index scores of the menopausal women were found to be lower in the intervention group than in the control group (p=0.011, p=0.001, and p=0.006, respectively). When the pre-test and post-test mean scores were compared, the mean menopausal symptoms and depression levels decreased, and sleep quality increased significantly in the intervention group. No significant difference was observed in the control group. CONCLUSION: This study shows that music may have an effect on reducing the level of menopausal symptoms and depression levels and also increasing the sleep quality of menopausal women.

Los significados de la menopausia, una mirada desde la teoría de las transiciones

Introducción: La menopausia es una etapa, si bien normal, de profundos cambios en la vida de la mujer; la transición hacia la menopausia impone un reto al profesional de enfermería, encaminado a promover la salud, facilitar la transición y apoyar la búsqueda de solución a las necesidades que se presentan. Objetivo: El presente estudio está orientado a comprender los significados de la menopausia en mujeres de Armenia, Quindío, Colombia. Metodología: Se utilizó un enfoque cualitativo, fenomenológico e interpretativo desde la teoría de las transiciones de Meléis. Se efectuaron entrevistas a profundidad a seis mujeres de Armenia, previo consentimiento informado, con muestreo intencional, grabación y diario de campo; la información se analizó con apoyo de la base de datos ATLAS.ti, mediante codificación, categorización inductiva, triangulación y contestación con la literatura. Resultados: Se encontró una percepción negativa de la menopausia por sensación de fogajes, desasosiego, depresión y disfunción sexual; para los síntomas recurren a terapias complementarias y medicación, al respecto, algunas refieren una experiencia tranquilizadora y agradable. Urgen redes de acompañamiento en salud para promoción, prevención y apoyo familiar. Las participantes solicitan programas educativos específicos desde edades tempranas. Discusión: Los resultados coinciden con la literatura en cuanto a la experiencia de las participantes y la necesidad de apoyo y orientación. Desde la teoría de Meléis, la transición es de desarrollo, organizacional, con patrones múltiples, simultáneos y relacionados. La experiencia fue sentida y vivida negativamente, se necesitan espacios de análisis, reflexión y acompañamiento desde edades tempranas, para deconstruir el concepto de menopausia y climaterio como problema de salud, y abordarlo como evento vital y de renacimiento, como apertura a una nueva forma de vivir, con estilos de vida saludables. Conclusiones: Se concluye que la menopausia es percibida y experimentada como una etapa de ansiedad, desasosiego, tristeza y desesperanza, por el poco acompañamiento, deficiente educación y preparación de la mujer; las mujeres adultas "menopaúsicas" son poco reconocidas, rechazadas, y muchas veces solo toleradas por personas cercanas. Urgen redes de acompañamiento en salud.

Introduction: Menopause is a stage, although normal, of profound changes in a woman's life. The transition to menopause imposes a challenge on the nursing professional, aimed at promoting health, facilitating the transition and supporting the search for a solution to the needs that arise. Objective: The present study is aimed at understanding the meanings of menopause in women from Armenia, Quindio Department, Colombia. Metodology: A qualitative, phenomenological and interpretative approach was used, based on Meleis's theory of transitions. In-depth interviews were carried out on six women from Armenia, with prior informed consent, with intentional sampling, recording, and field diary; the information was analyzed with support of the ATLAS.ti database, through coding, inductive categorization, triangulation, and comparison with the literature. Results: A negative perception of menopause was found due to hot flashes, restlessness, depression and sexual dysfunction; for the symptoms they resort to complementary therapies and medication, as a result, some report a calming and pleasant experience; health accompaniment networks are urgently needed for promotion and prevention, and family support. They request specific educational programs from an early age. Discussion. The results coincide with the literature regarding the experience of the participants and the need for support and guidance. From Meleis's theory, the transition is developmental, organizational, with multiple, simultaneous and related patterns. The experience was felt and lived negatively, spaces for analysis, reflection and accompaniment are needed from an early age, to deconstruct the concept of menopause and climacteric as a health problem, and address it as a vital and rebirth event, as an opening to a new way of living, with healthy lifestyles. Conclusions: It is concluded that the menopause is perceived and experienced as a stage of anxiety, restlessness, sadness and hopelessness, due to the lack of accompaniment, poor education and preparation of women; "menopausal" adult women are little recognized, rejected and, many times, only tolerated by close people. Health support networks are urgently needed.

Incidence and Outcomes Associated with Menopausal Status in COVID-19 Patients: A Systematic Review and Meta-analysis / Incidência e resultados associados ao estado da menopausa em pacientes com COVID-19: Uma revisão sistemática e metanálise

Abstract Objective Menopause causes several changes in the body that may affect the response to COVID-19. We aimed to investigate the possible association between menopausal status and incidence and outcomes in COVID-19 patients. Methods Combinations of keywordsCOVID-19, menopause, and estrogen were used to search the PubMed, Embase, Web-of-Science, and Scopus databases for articles reporting the incidence and outcomes of COVID-19 (discharge, length-of-admission, intensive care, or mortality) in premenopausal women, available through December 29, 2022. Data from studies comparing the incidence of COVID-19 infection with the age-matched male population were pooled and meta-analyzed using a random-effects model. Results Overall, 1,564 studies were retrieved, of which 12 were finally included in the systematic review to compare disease outcomes, and 6 were meta-analyzed for the incidence of COVID-19 in premenopausal and postmenopausal women. All studies reported better COVID-19-associated outcomes in premenopausal women compared with postmenopausal women. After adjusting for confounding factors, three studies found better outcomes in postmenopausal women, and two found no association between menopausal status and COVID-19 outcomes. Our meta-analysis found a higher incidence of COVID-19 infection among premenopausal women than postmenopausal women, when compared with age-matched men (odds ratio = 1.270; 95% confidence interval: 1.086-1.486; p= 0.003). Conclusion The incidence of COVID-19 was significantly higher in premenopausal women than in postmenopausal women when compared with age-matched men. Although premenopausal women may have more favorable COVID-19-associated outcomes, the presumed preventive effect of estrogens on the incidence and related outcomes of COVID-19 in premenopausal women cannot be proven at present. Further longitudinal studies comparing pre- and post-menopausal women are required to provide further insight into this matter.

Resumo Objetivo A menopausa causa diversas alterações no corpo que podem afetar a resposta ao COVID-19. Nosso objetivo foi investigar a possível associação entre o status da menopausa e a incidência e os resultados em pacientes com COVID-19. Métodos Combinações de palavras-chave COVID-19, menopausa e estrogênio foram usadas para pesquisar os bancos de dados PubMed, Embase, Web-of-Science e Scopus para artigos relatando a incidência e os resultados do COVID-19 (alta, tempo de internação, tratamento intensivo cuidados ou mortalidade) em mulheres na pré-menopausa, disponível até 29 de dezembro de 2022. Dados de estudos comparando a incidência de infecção por COVID-19 com a população masculina da mesma idade foram agrupados e meta-analisados usando um modelo de efeitos aleatórios. Resultados No geral, 1.564 estudos foram recuperados, dos quais 12 foram finalmente incluídos na revisão sistemática para comparar os resultados da doença e 6 foram meta-analisados para a incidência de COVID-19 em mulheres na pré e pós-menopausa. Todos os estudos relataram melhores resultados associados ao COVID-19 em mulheres na pré-menopausa em comparação com mulheres na pós-menopausa. Após o ajuste para fatores de confusão, três estudos encontraram melhores resultados em mulheres na pós-menopausa e dois não encontraram associação entre o status da menopausa e os resultados do COVID-19. Nossa meta-análise encontrou uma maior incidência de infecção por COVID-19 entre mulheres na pré-menopausa do que mulheres na pós-menopausa, quando comparadas com homens da mesma idade (odds ratio = 1,270; intervalo de confiança de 95%: 1,086-1,486; p = 0,003). Conclusão A incidência de COVID-19 foi significativamente maior em mulheres na pré-menopausa do que em mulheres na pós-menopausa quando comparadas com homens da mesma idade. Embora as mulheres na pré-menopausa possam ter resultados mais favoráveis associados ao COVID-19, o efeito preventivo presumido dos estrogênios na incidência e nos resultados relacionados ao COVID-19 em mulheres na pré-menopausa não pode ser comprovado no momento. Mas estudos longitudinais comparando mulheres pré e pós-menopausa são necessários para fornecer mais informações sobre este assunto.

Confiabilidad de cuestionarios electrónicos para evaluar calidad de vida y actitudes hacia la vejez en mujeres de 40 a 69 años / Reliability of electronic questionnaires to evaluate quality of life and attitudes towards old age in women aged 40 to 69 years

Introducción: el uso de cuestionarios electrónicos se ha convertido en algo común, sin embargo, depende de diversos factores (como la edad y las habilidades digitales), por lo que es necesario determinar la confiabilidad de estos instrumentos para su aplicación. Objetivo: determinar la concordancia y reproducibilidad de los cuestionarios Calidad de vida breve de la OMS (WHOQoL-B) y Actitudes autoevaluadas hacia la vejez (AAV) en formato electrónico para su aplicación vía remota a mujeres de edad madura y adulta mayor. Metodología: se realizó un estudio instrumental con el método test-retest con 35 mujeres (40-69 años). Se transfirieron ambos cuestionarios a un formulario de Google y se enviaron vía WhatsAppen dos ocasiones, con una diferencia mayor a 15 días entre la aplicación. Se calcularon los parámetros de confiabilidad por estabilidad temporal y concordancia estadística. Resultados: el WHOQoL-B obtuvo a y CCI = 0.880 y r = 0.785 en la calificación total; para sus dimensiones a > 0.740 y r > 0.590. La calificación total del AAV mostró a y CCI = 0.708 y r = 0.552 y sus dimensiones a > 0.710 y r de 0.295 a 0.508. Conclusiones: los cuestionarios WHOQoL-B y AAV en formato electrónico pueden ser utilizados para aplicación vía remota, aunque el AAV es menos consistente...(AU)

Abstract Introduction: The electronic tests have been used on a regular basis, although their use depends on several factors such as age and digital ability, therefore it is necessary to determine the confidence of these instruments for their application. Objective: To determine the agreement and reproducibility of the WHO Quality of Life-Bref (WHOQoL-B) and the Self-Assessed Attitudes Towards Old Age (SATO) questionnaires in electronic format for application in middle-aged and older women. Methods: An instrumental study with a test-retest method was carried out with 35 women (40-69 years). Both questionnaires were transferred to a Google form and sent to the women by WhatsApp twice with a difference of more than 15 days between applications. We calculate the confidence by temporal stability and the statistical agreement. Results: For the WHOQoL-B, an a and ICC= 0.880, and r = 0.785 were obtained in the total rating; for their dimensions the result for a was > 0.740, and r > 0.590. The total rating of SATO shows an a and ICC= 0.708, and r = 0.552; for their dimensions, the a was > 0.710, and r from 0.295 to 0.508. Conclusions: The electronic tests WHOQoL and SATO can be used for remote application, although SATO is less consistent.

Nutrição no climatério: quais os benefícios? Revisão integrativa / Nutrition in Menopause: What are the Benefits? An Integrative Review / Nutrición en el Climaterio: ¿Cuáles son los Beneficios? Una Revisión Integradora

Introdução:A menopausa é uma fase transitória entre o período reprodutivo para o período não fértil na vida da mulher, sendo dividido em três períodos: pré-menopausa, perimenopausa e pós-menopausa, podendo durar de 12 meses a 03 anos. Anutrição e a alimentação possuem um importante papel durante esse período, visando evitar ou minimizar problemas como: osteoporose, constipação, desidratação, hipertensão, ansiedade, diminuição da libido, depressão, alterações no sono, dores nas articulações e ganho de peso. Objetivo:Descrever os possíveis benefícios relacionados à nutrição durante o climatérioMetodologia:Revisão da literatura que utilizou as bases de dados Biblioteca Virtual em Saúde (BVS), National Library of Medicine (PubMed) e Scientific Electronic Library Online (Scielo), por meio dos Descritores em Ciência da Saúde (DeCS) "Diet", "Climacteric" combinados com o operador booleano AND. Nossa pesquisa considerou estudos originais publicados nos últimos cinco anos, tanto de acesso livre quanto restrito, sem restrição de idioma. Excluímos revisões, duplicatas e artigos não relacionados ao tema. Encontramos um total de 122 artigos com os descritores utilizados e selecionamos 19 para a amostra desta revisão. Resultados:Observou-se uma perda de peso significativa entreas mulheres no climatério, assim como ondas de calor em decorrência dos sintomas da menopausa. A compulsão alimentar dos grupos randomizados mostrou-se baixa bem como a pressão arterial. Pode-se constatar, ainda, que o IMC dessas mulheres apresentou declínio e os sintomas relacionados à depressão igualmente registraram uma redução. Conclusões:A intervenção nutricional no climatério resultou em benefícios significativos, incluindo perda de peso, redução dos sintomas da menopausa, melhora da saúde cardiovascular, diminuição do IMC e alívio dos sintomas relacionados à depressão. Esses resultados destacam a importância da nutrição como uma abordagem eficaz para melhorar a qualidade de vida das mulheres nessa fase de transição (AU).

Introduction:Menopause is a transitional phase between the reproductive and the non-fertile periods of women, divided into pre-menopause, perimenopause and post-menopause, lasting from 12 months to 3 years. Nutritionand diet play a relevant role, aiming to avoid or minimize problems such as osteoporosis, constipation, dehydration, hypertension, anxiety, decreased libido, depression, changes in the sleep cycle, joint pain, and weight gain. Objective:Describing the possible benefits related to nutrition during menopause. Methodology:AThis paper presents a literature review that used the Virtual Health Library (VHL), National Library of Medicine (PubMed) and Scientific Electronic Library Online (Scielo) databases, through the Health Science Descriptors (DeCS) "Diet", "Climacteric" combined with the Boolean operator AND. The research considered original studies published in the last five years, both of open and restricted access, without restrictions for languages. Reviews, duplicates and articles unrelated to the topic were excluded. A total of 122 articles were found using these descriptors, and 19 were selected for the sample of this review. Results:Significant weight loss was observed among climacteric women, as well as hot flashes due to menopausal vasomotor symptoms. Binge eating in the randomized groups was low, as was blood pressure. It was also observed that the BMI of these women showed a decline and symptoms related to depression were also reduced. Conclusions:A nutritional intervention during menopause resulted in significant benefits, including weight loss, reduced symptoms, improved cardiovascular health, decreased BMI, and relief of symptoms related to depression. The importance of nutrition is highlighted as an effective approach to improve the quality of life of women in this transition phase (AU).

Introducción: La menopausia es una fase transitoria entre el período reproductivo y el período no fértil en la vida de la mujer, siendo dividido en tres fases: premenopausia, perimenopausia y posmenopausia, pudiendo durar de 12 meses a 03 años. La nutrición y la alimentación tienen un importante papel durante este período, buscando evitar o minimizar problemas como: osteoporosis, estreñimiento, deshidratación, hipertensión, ansiedad, disminución de la libido, depresión, cambios en el sueño, dolor en las articulaciones y aumento de peso. Objetivo: Describir los posibles beneficios relacionados con la nutrición durante el climaterioMetodología: Revisión de la literatura que utilizó las bases de datos Biblioteca Virtual en Salud (BVS), National Library of Medicine (PubMed) y Scientific Electronic Library Online (Scielo), por medio de los descriptores en Ciencia de la Salud (DeCS) "Diet", "Climacteric" combinados con el operador booleano AND. Nuestra investigación consideró estudios originales publicados en los últimos cinco años, tanto de acceso libre como restringido, sin limitación de idiomas. Excluimos revisiones, duplicados y artículos no relacionados con el tema. Encontramos un total de 122 artículos con los descriptores utilizados y seleccionamos 19 para la muestra de esta revisión. Resultados: Se observó una pérdida de peso significativa entre las mujeres en el climaterio, al igual que una reducción de loscalores súbitos como consecuencia de los síntomas de la menopausia. La compulsión alimentaria de los grupos aleatorizados demostró ser baja, así como la presión arterial. Se puede constatar, además, que el IMC de esas mujeres presentó una disminución y los síntomas relacionados a la depresión igualmente registraron una reducción. Conclusiones: La intervención nutricional en el climaterio ocasionó beneficios significativos, incluyendo pérdida de peso, reducción de los síntomas de la menopausia, mejora de la salud cardiovascular, disminución del IMC y alivio de los síntomas relacionados con la depresión. Estos resultados resaltan la importancia de la nutrición como un enfoque efectivo para mejorar la calidad de vida de las mujeres en esta fase de transición (AU).

Prevalencia y caracterización de las disfunciones sexuales en mujeres en transición a la menopausia / Prevalence and characterization of sexual dysfunctions in women in transition to menopause

Objetivo: Caracterizar las disfunciones sexuales y estimar la prevalencia en un grupo de mujeres en transición a la menopausia, así como evaluar la frecuencia de la sintomatología climatérica. Método: Estudio de corte transversal, entre 2017 y 2020, que incluyó 411 mujeres en transición a la menopausia, residentes en el Quindío, con pareja estable y actividad sexual en las últimas 6 semanas. Se utilizó como instrumento el FSFI-6 (6-Item Female Sexual Function Index). Resultados: La edad promedio fue de 46,53 ± 2,87 años. La prevalencia de disfunciones sexuales fue del 38,92%, caracterizadas por dificultades con el deseo sexual (38,92%), seguido de dolor/dispareunia (35,52%). El promedio general en la puntuación del FSFI-6, en la totalidad de la población participante, fue de 22,29 ± 0,84 puntos; en la población afectada (< 19 puntos) fue de 15,78 ± 3,94. En los dominios, la puntuación más baja estuvo en el deseo (3,14 ± 0,56). La mediana de disfunciones sexuales por mujer fue de tres (23,84%). Conclusiones: más de un tercio de las mujeres del Quindío en transición a la menopausia presentan disfunciones sexuales; el trastorno más común fue el bajo deseo. Se deben hacer esfuerzos para aumentar la conciencia en los asuntos de salud sexual.

Objective: To characterize sexual dysfunctions and estimate the prevalence in a group of women in transition to menopause, as well as to evaluate the frequency of climacteric symptoms. Method: Cross-sectional study, between 2017 and 2020, included 411 women in transition to menopause, residents of Quindío, with a stable partner and sexual activity in the last 6 weeks. The FSFI-6 (6-Item Female Sexual Function Index) was used as an instrument. Results: The mean age was 46.53 ± 2.87 years. The prevalence of sexual dysfunctions was 38.92%, characterized by difficulties with sexual desire (38.92%), followed by pain/dyspareunia (35.52%). The general average, in the FSFI-6 score, in the entire participating population, was 22.29 ± 0.84 points; while in the affected population (< 19 points), it was 15.78 ± 3.94. In the domains, the lowest score was in desire (3.14 ± 0.56). The median number of sexual dysfunctions per woman was three (present in 23.84%). Conclusions: This study showed that more than one third of the women in Quindío, in transition to menopause, had sexual dysfunctions; the most common type of disorder was low desire. Efforts should be made to increase awareness about sexual health issues.

La relación entre la transición a la menopausia y los trastornos del estado de ánimo / The relationship between menopause transition and mood disorders

Este estudio tuvo como objetivo examinar la relación entre la transición a la menopausia y los trastornos del estado de ánimo, específicamente la ansiedad y la depresión. Se llevó a cabo una revisión narrativa de la literatura relevante sobre la transición a la menopausia y los trastornos del estado de ánimo. Se revisaron estudios que se enfocaron en el impacto de los cambios hormonales durante la menopausia en el bienestar psicológico y se evaluaron diversas opciones de tratamiento para los trastornos del estado de ánimo. La disminución de los niveles hormonales de estrógenos y progesterona durante la menopausia puede llevar a diversos cambios psicológicos, como ansiedad y depresión. La terapia hormonal con estrógenos solo o en combinación con progesterona puede mejorar los síntomas depresivos en mujeres en la menopausia, pero este tratamiento no está exento de riesgos. Otros tratamientos no hormonales, como la terapia cognitivo-conductual, el ejercicio y una buena higiene del sueño, también pueden ser efectivos para manejar los trastornos del estado de ánimo. Se concluyó que existe una compleja interacción entre factores hormonales, biológicos y psicosociales para desarrollar intervenciones efectivas que mejoren el bienestar psicológico de las mujeres en la menopausia.

This study aimed to examine the relationship between menopause transition and mood disorders, specifically anxiety and depression. The authors conducted a narrative review of relevant literature on menopause transition and mood disorders. They reviewed studies that focused on the impact of hormonal changes during menopause on psychological well-being and evaluated various treatment options for mood disorders. The decline in estrogen and progesterone hormone levels during menopause can lead to various psychological changes, such as anxiety and depression. Hormonal therapy with estrogen alone or in combination with progesterone can improve depressive symptoms in menopausal women, but this treatment is not without risks. Other non-hormonal treatments, such as cognitive-behavioral therapy, exercise, and good sleep hygiene, can also be effective in managing mood disorders. The study highlights the need for recognition of the complex interplay between hormonal, biological, and psychosocial factors in developing effective interventions to improve the psychological well-being of menopausal women. Further research is needed to fully understand the potential relationship between menopause transition and mood disorders.

Menopausia quirúrgica en pacientes con mutación BRCA, el papel de la terapia hormonal / Surgical Menopause in Patients with BRCA Mutation, the Role of Hormone Therapy

Introducción: las mujeres con mutación BRCA1/2 (mBRCA) tienen un riesgo aumentado de desarrollar cáncer de mama (CM) y ovario (CO). La salpingo-oforectomía bilateral (SOB) se asocia con la reducción del riesgo del 80% para CO y un 50% para CM. Se recomienda realizarla entre los 35 y 40 años. Como consecuencia se produce una menopausia prematura, con un impacto negativo sobre la calidad de vida por la presencia de síntomas climatéricos, aumento del riesgo de enfermedad cardiovascular, osteoporosis y riesgo de alteración cognitiva. La terapia hormonal (THM) es el tratamiento más eficaz para la prevención de estos síntomas. Estado del arte: distintos estudios han demostrado un mayor riesgo de CM en mujeres posmenopáusicas que reciben THM en particular con terapia combinada, estrógeno + progesterona (E+P). Según el metanálisis de Marchetti y cols., en las mujeres portadoras de mBRCA que recibieron THM, no hubo diferencias en el riesgo de CM comparando E solo con E+P. En el estudio de Kotsopoulos, incluso se encontró un posible efecto protector en aquellas que usaron E solo. Otro estudio en portadoras sanas demostró que, en las mujeres menores de 45 años al momento de la SOB, la THM no afectó las tasas de CM. Sin embargo, en las mujeres mayores de 45 años, las tasas de CM fueron más altas. Como el esquema de E+P se asocia con un mayor riesgo relativo (RR) de CM, las dosis de progestágenos utilizados se deberían limitar, eligiendo derivados naturales de progesterona, de uso intermitente para disminuir la exposición sistémica. Según diferentes guías internacionales, a las portadoras de mBRCA sanas que se someten a una SOB se les debe ofrecer THM hasta la edad promedio de la menopausia. Conclusión: la menopausia prematura disminuye la expectativa de vida; es por ello que una de las herramientas para mejorar y prevenir el deterioro de la calidad de vida es la THM. El uso de THM a corto plazo parece seguro para las mujeres portadoras de mBRCA que se someten a una SOB antes de los 45 años, al no contrarrestar la reducción del riesgo de CM obtenida gracias a la cirugía. (AU)

Introduction: women with BRCA1/2 (mBRCA) mutation have an increased risk of developing breast (BC) and ovarian (OC) cancer. Bilateral salpingo-oophorectomy (BSO) is associated with an 80% risk reduction for OC and 50% for BC. The recommended age for this procedure is 35 to 40 years. The consequence is premature menopause, which hurts the quality of life due to the presence of climacteric symptoms, increased risk of cardiovascular disease, osteoporosis, and a higher risk of cognitive impairment. Hormone therapy (MHT) is the most effective treatment for preventing these symptoms. State of the art: different studies have shown an increased risk of BC in postmenopausal women receiving MHT, particularly with combined therapy, estrogen + progesterone (E+P). According to the meta-analysis by Marchetti et al., in women carrying mBRCA who received MHT, there was no difference in the risk of BC compared to E alone with E+P. In the Kostopoulos study, there was also a possible protective effect in those who used E alone. Another study in healthy carriers showed that in women younger than 45 years at the time of BSO, MHT did not affect BC rates. However, in women older than 45 years, BC rates were higher. As the E+P scheme is associated with a higher RR of BC, the doses of progestogens should be limited, choosing natural progesterone byproducts of intermittent use to decrease systemic exposure. According to various international guidelines, healthy mBRCA carriers undergoing BSO should be offered MHT until the average age of menopause. Conclusion: premature menopause decreases life expectancy, which is why one of the tools to improve and prevent deterioration of quality of life is MHT. Short-term use of MHT appears safe for women with mBRCA who undergo BSO before age 45 as it does not counteract the reduction in the risk of MC obtained by surgery. (AU)

Association Between Hormone Therapy and Weight Gain in the Menopause Transition and After Menopause: A Systematic Review and Meta-Analysis

Objectives: to conduct a systematic review and meta-analysis in order to assess whether hormone therapy (HT) increases weight in women in the menopausal transition and after menopause. Method: this article proposes an update to the systematic review published in 2005 by the Cochrane Library (Kongnyuy EJ et al 2005) with reference to studies assessing weight changes in women receiving HT from 1986 to 2005. Following PRISMA recommendations, we included randomized controlled trials (RCTs) ) from May 2005 onwards from Medline, Embase, and the Cochrane CENTRAL databases. Standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated. Two authors independently assessed the risk of biases in the selected studies. Results: ten RCTs were included, totaling 2,588 HT users and 764 non-users. Different regimens, dosages, and routes of administration in HT users were analyzed and compared to non-users. The results did not show statistically significant differences for most of the HT regimens evaluated. There was significant weight gain only in patients using EEC alone at dosages of 0.45 mg/day and 0.3 mg/day when compared to placebo (p 0.01); as well as in patients receiving esto-progestative combinations of 0.5 mg/day 17-beta-estradiol (E2) + 100 mg/day progesterone, with a 0.7 kg weight increase (p 0.032). On the other hand, the combinations of 1 mg/day estradiol valerate + 3 mg/day drospirenone showed a -1.0 kg reduction (p = 0.04), whereas a -0.2 kg reduction (p = 0.001) was identified in patients using 1 mg /day estradiol (E) + 0.5 mg norethisterone acetate (NETA). Tibolone therapy showed no statistically significant changes in weight. After performing a meta-analysis, the comparative results between users and non-users showed that there was a slight weight increase (+0.279 kg ; CI -1.71 to 2.27) in patients using 0.625 mg/day conjugated equine estrogen (CEE) + 2.5 mg/day medroxyprogesterone acetate (MPA). As for the patients receiving 2.5 mg/day Tibolone, weight gain (+0.670 kg; CI from -1.14 to 2.48) was also observed in them. However, these increases were not significant when compared to non-HT users. Conclusions: most regimens studied showed that patients using HT in the menopausal transition and after menopause did not show significant weight gain. The only combination that showed weight gain was 0.5 mg/day 17-beta-estradiol (E2) + 100 mg/day progesterone observed, while there was weight reduction in patients using 1 mg/day estradiol valerate + 3 mg/day drospirenone and 1 mg/day estradiol (E) + norethisterone acetate.

Objetivo: realizar uma revisão sistemática e meta-análise para avaliar se a terapia hormonal (TH) aumenta o peso em mulheres na transição menopausal e após a menopausa. Métodos: este artigo propõe uma atualização da revisão sistemática publicada em 2005 pela Cochrane Library (Kongnyuy EJ et al., 2005) com referência a estudos avaliando mudanças de peso em mulheres recebendo TH de 1986 a 2005. Seguindo as recomendações do PRISMA, incluímos ensaios clínicos randomizados (RCTs) de maio de 2005 em diante do Medline, Embase e dos bancos de dados Cochrane CENTRAL. Diferenças médias padronizadas (SMD) e intervalos de confiança de 95% (IC) foram calculados. Dois autores avaliaram independentemente o risco de vieses nos estudos selecionados. Resultados: foram incluídos dez ECRs, totalizando 2.588 usuários de HT e 764 não usuários. Diferentes esquemas, dosagens e vias de administração em usuários de HT foram analisados e comparados a não usuários. Os resultados não mostraram diferenças estatisticamente significativas para a maioria dos esquemas de TH avaliados. Houve ganho de peso significativo apenas nos pacientes que usaram apenas EEC nas doses de 0,45 mg/dia e 0,3 mg/dia quando comparados ao placebo (p 0,01); assim como em pacientes recebendo combinações estoprogestativas de 0,5 mg/dia de 17-beta-estradiol (E2) + 100 mg/dia de progesterona, com aumento de peso de 0,7 kg (p 0,032). Por outro lado, as combinações de 1 mg/dia de valerato de estradiol + 3 mg/dia de drospirenona apresentaram redução de -1,0 kg (p = 0,04), enquanto foi identificada redução de -0,2 kg (p = 0,001) nas pacientes que usaram 1 mg /dia estradiol (E) + 0,5 mg de acetato de noretisterona (NETA). A terapia com tibolona não mostrou alterações estatisticamente significativas no peso. Após realizar uma meta-análise, os resultados comparativos entre usuárias e não usuárias mostraram que houve um leve aumento de peso (+0,279 kg ; IC -1,71 a 2,27) em pacientes em uso de 0,625 mg/dia de estrogênio equino conjugado (CEE) + 2,5 mg/dia de acetato de medroxiprogesterona (MPA). Quanto aos pacientes que receberam Tibolona 2,5 mg/dia, também foi observado ganho de peso (+0,670 kg; IC de -1,14 a 2,48). No entanto, esses aumentos não foram significativos quando comparados aos não usuários de HT. Conclusões: a maioria dos esquemas estudados mostrou que as pacientes em uso de TH na transição menopausal e após a menopausa não apresentaram ganho de peso significativo. A única combinação que apresentou ganho de peso foi 0,5 mg/dia de 17-beta-estradiol (E2) + 100 mg/dia de progesterona, enquanto houve redução de peso nas pacientes que usaram 1 mg/dia de valerato de estradiol + 3 mg/dia de drospirenona e 1 mg/dia estradiol (E) + acetato de noretisterona.

Climatério e lúpus eritematoso sistêmico / Climacteric and systemic lupus erythematosus

O lúpus eritematoso sistêmico é uma doença crônica, complexa e multifatorial que apresenta manifestações em vários órgãos. O seu acometimento ocorre 10 vezes mais no sexo feminino do que no masculino. É uma doença com uma clínica variada e com graus variados de gravidade, causando fadiga, manifestações cutâneas, como rash malar, fotossensibilidade, queda de cabelo e manifestações musculoesqueléticas, como artralgia, mialgia e atrite. Podem ocorrer flares (crises), que se caracterizam por aumento mensurável na atividade da doença. No climatério, no período da pré-menopausa, o lúpus eritematoso sistêmico ocorre com mais frequência, podendo ocorrer também na pós-menopausa. Algumas doenças são mais frequentes na fase do climatério, e a presença do lúpus pode influenciar na sua evolução, como a doença cardiovascular, osteoporose e tromboembolismo venoso. A terapia hormonal oral determina aumento do risco de tromboembolismo venoso no climatério, e na paciente com lúpus eritematoso sistêmico há aumento dos riscos de flares e de trombose. Em vista disso, a terapia hormonal é recomendada apenas para pacientes com lúpus eritematoso sistêmico estável ou inativo, sem história de síndrome antifosfolípides e com anticorpos antifosfolípides negativa, devendo-se dar preferência para a terapia estrogênica transdérmica, em menor dose e de uso contínuo. Na paciente com lúpus eritematoso sistêmico ativo ou com história de síndrome antifosfolípides ou com anticorpos antifosfolípides positiva, recomenda-se a terapia não hormonal, como os antidepressivos. (AU)

Systemic lupus erythematosus is a chronic, complex, multifactorial disease that manifests in several organs. Its involvement occurs 10 times more in females than in males. It is a disease with a varied clinic and varying degrees of severity, causing fatigue, skin manifestations such as malar rash, photosensitivity, hair loss and musculoskeletal manifestations such as arthralgia, myalgia and arthritis. Flare may occur, which are characterized by measurable increase in disease activity. In the climacteric, in the premenopausal period, systemic lupus erythematosus occurs more frequently, and may also occur in the postmenopausal period. Some diseases are more frequent in the Climacteric phase and the presence of lupus can influence its evolution, such as cardiovascular disease, osteoporosis and venous thromboembolism. Oral hormone therapy determines an increased risk of venous thromboembolism in the climacteric and in patients with systemic lupus erythematosus there is an increased risk of flares and thrombosis. In view of this, hormone therapy is only recommended for patients with stable or inactive systemic lupus erythematosus, without a history of antiphospholipid syndrome and with antiphospholipid antibodies, giving preference to transdermal estrogen therapy, at a lower dose and for continuous use. In patients with active systemic lupus erythematosus or with a history of antiphospholipid syndrome or positive antiphospholipid antibodies, non-hormonal therapy, such as antidepressants, is recommended. (AU)

AN ANALYTICAL STUDY OF ABNORMAL UTERINE BLEEDING IN WOMEN OF PERIMENOPAUSAL AGE GROUP

BACKGROUND: Abnormal uterine bleeding complaints constitute about one-third ofpatients attending the Obstetrics and Gynaecology OPD. To standardize nomenclature ofAUB, a new system known by the acronym PALM-COEIN, was introduced in 2011 byFIGO.AIMS AND OBJECTIVES:To study the various abnormal patterns of bleeding presenting in perimenopausal agegroup.To study the etiology, predisposing and associated factors of AUB.To study the various treatment options available for AUB.METHODS: This study was carried in department of obstetrics and gynaecology amongperimenopausal women attending out patient department. The clinical presentation,ultrasonographic findings associated medical disorders, routes of hysterectomy werecorelated.RESULTS: Menorrhagia is the predominant symptom of 109 patients. 101 were associatedwith complain of heavy menstrual bleeding followed by dysmenorrhea. Adenomyosis wasthe most common abnormality found on TVS followed by Endometrial Hyperplasia,Fibroid and polyp. Treatment was initiated in form of conservative medical therapyfollowed by, combination therapy of hormonal drugs-Progesterone and COC and nonhormonal drugs like tranexamic acid + mefenamic acid were used to control bleeding.Hysterectomy was served as a final measure for all patients who didn’t respond toconservative management.CONCLUSION: AUB is a common problem in peri-menopausal age group and itsaccounts for one third of patients visiting Gynecological OPD. It significantly affects thequality of life in general population.

Efectos de la menopausia temprana en la función pulmonar: revisión integrativa / Effects of early menopause on lung function: an integrative review

La menopausia provoca cambios hormonales y alteraciones sistémicas. La menopausia normal sucede entre los 45-55 años y la menopausia temprana (MT) se desarrolla antes de los 45 años. Revisar la evidencia que señala posibles asociaciones entre la MT y la función pulmonar, analizando específicamente aquellos componentes que se encuentran alterados. Se eligieron estudios transversales y revisiones sistemáticas, en inglés, portugués y español. La búsqueda se realizó de marzo a noviembre de2022, en PubMed y Scopus, aemás de búsquedas manuales. La calidad metodológica fue analizada utilizando la escala Strengthening the Reporting of Observational Studies in Epidemiology para los estudios observacionales, y el Ameasurement Tool to Assess Systematic Review para las revisiones. Se encontraron 698 estudios, 12 seleccionados para calificación metodológica, cinco excluidos. Al final del análisis metodológico, se obtuvieron seis estudios transversales y una revisión sistemática, llevados a cabo en Reino Unido, Europa y Asia. Hay una tendencia para asociación de la MT a un patrón ventilatorio restrictivo. Sin embargo la evidencia sigue siendo escasa y se sugiere la realización de nuevos estudios.

Menopause causes hormonal changes and systemic alterations. Normal menopause is when this event occurs between the ages of 45 and 55, and early menopause (EM) when it develops earlier than 45 years. To review the evidence that indicates possible associations between EM and lung function, specifically analyzing those components that are altered. Cross-sectional and systematic reviews studies, published from 2000-2022, in English, Portuguese and Spanish were selected from March to November 2022, in PubMed and Scopus and through manual searches. Methodological quality was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology scale for observational studies, and the Measurement Tool to Assess Systematic Review for reviews. 698 studies were found, 12 were selected for methodological quality review and 5 were excluded. At the end of methodological analysis, 6 cross-sectional studies and 1 systematic review were obtained, carried out in United Kingdom, Europe and Asia. There is a tendency for EM to be associated with restrictive ventilatory pattern. However, the evidence is scarce and further studies are suggested.

Avaliação de sintomas climatéricos em mulheres jovens submetidas à quimioterapia / Assessment of climacteric symptoms in young women undergoing chemotherapy / Evaluación de síntomas climatéricos en mujeres jóvenes sometidas a quimioterapia

RESUMO Objetivo: Descrever a prevalência de sintomas climatéricos em mulheres submetidas a tratamento oncológico e analisar sua relação com a quantidade de ciclos quimioterápicos. Métodos: Estudo transversal com 47 mulheres submetidas à quimioterapia em dois hospitais de referência oncológica de São Luís, Maranhão, Brasil, entre março de 2019 e julho de 2020. Utilizou-se questionário estruturado contendo variáveis sociodemográficas e informações sobre função menstrual e sintomas. Foram realizadas análise bivariada e regressão logística binária para avaliar a relação entre as variáveis previsoras e quantidade de ciclos quimioterápicos. Resultados: Média de idade de 31,71 anos, amenorreia e fogacho, foram os sintomas mais frequentes, porém, sem relação com o número de ciclos quimioterápicos. Não houve associação entre a presença de efeitos climatéricos com o tipo de quimioterapia (p=0,15). Conclusão: Reafirma-se que quimioterápicos podem causar sintomas climatéricos enfatizando a necessidade de medidas para amenizar os sintomas nas pacientes que enfrentam essa problemática.

ABSTRACT Objective: To describe the prevalence of climacteric symptoms in women undergoing cancer treatment and to analyze its relationship with the number of chemotherapy cycles. Methods: Cross-sectional study with 47 women undergoing chemotherapy in two cancer reference hospitals in São Luís, Maranhão, Brazil, between March 2019 and July 2020. A structured questionnaire was used containing sociodemographic variables and information on menstrual function and symptoms. Bivariate analysis and binary logistic regression were performed to assess the relationship between predictor variables and number of chemotherapy cycles. Results: Mean age was 31.71 years, and amenorrhea and hot flushes were the most frequent symptoms, however, unrelated to the number of chemotherapy cycles. There was no association between the presence of climacteric effects and the type of chemotherapy (p=0.15). Conclusion: The results reaffirmed that chemotherapy can cause climacteric symptoms, thus emphasizing the need for measures to alleviate symptoms in patients facing this problem.

RESUMEN Objetivo: Describir la prevalencia de síntomas climatéricos en mujeres sometidas a tratamiento oncológico y analizar su relación con la cantidad de ciclos quimioterápicos. Métodos: Estudio transversal con 47 mujeres sometidas a quimioterapia en dos hospitales oncológicos de referencia de São Luis, Maranhão, entre marzo de 2019 y julio de 2020. Se utilizó cuestionario estructurado incluyendo variables sociodemográficas e información sobre función menstrual y síntomas. Fueron practicados análisis bivariado y regresión logística binaria para evaluar la relación entre las variables de previsión y la cantidad de ciclos quimioterápicos. Resultados: Media etaria de 31,71 años, los síntomas más frecuentes fueron amenorrea y sofocos, aunque sin relación con la cantidad de ciclos quimioterápicos. No hubo asociación entre presencia de efectos climatéricos y tipo de quimioterapia (p=0,15). Conclusión: Se reafirma que los quimioterápicos pueden causar síntomas climatéricos, enfatizándose la necesidad de medidas para aliviar los síntomas en las pacientes que enfrentan esta problemática.

Evaluation of Salivary IL?8 and Calcium Levels in Postmenopausal Females with and without Periodontitis—A Comparative Study

Background and Objective: Menopause is a normal developmental stage in a woman’s life marking the permanent cessation of menstruation. Calcium is predominant in intracellular signalling and its intracellular increase can affect the cell’s proliferation, phagocytosis and cytokine secretion. IL?8 expression in various cells such as neutrophils and osteoblasts was reported to involve a calcium signalling pathway. Well?known functions of IL?8 includes help in angiogenesis, role in tumour progression, tissue remodelling, etc., Hence, the aim of this study was to establish the relationship between calcium?dependent IL?8 and periodontal disease in postmenopausal females. Method: The study population included 52 postmenopausal women aged 45–57 years. The patients were divided into two groups in which group I included postmenopausal women without periodontitis and group II with periodontitis. Unstimulated salivary samples were collected from all the participants to evaluate IL?8 and calcium levels. Results: There was a statistically significant difference in salivary IL?8 levels between the two groups (P < 0.001), but there was no statistical difference in salivary calcium levels between the two groups (P = 0.730). A weak negative correlation between salivary IL?8 and calcium was found in group I, while a weak positive correlation was found between the same in group II. Conclusion: Analysis of salivary IL?8 from the present study was in accordance with several previous studies. It can be concluded that saliva can also be used as a reliable oral diagnostic fluid for IL?8 and calcium detection in periodontitis.

Adiposity Indices as Predictors for Metabolic Syndrome Among Bangladeshi Women: A Cross Sectional Study

Background: The metabolic syndrome (MS) is described by the clustering of several risk factors for cardiovascular disease (CVD) such as hypertension, dyslipidemia, obesity, insulin resistance, and high fasting plasma glucose. The prevalence of MS is increasing worldwide and previous studies have shown that MS and CVD are more common in women above 55 years of age in the post menopausal phase. The aim of this study was to determine the prevalence of metabolic syndrome and adiposity indices as predictors and the related risk factors among Bangladeshi women. Material & Methods: This was a cross-sectional study and was conducted in the Outpatient departments of Bangladesh Medical College Hospital, Dhaka, Bangladesh during the period from May, 2022 to October, 2022. There was total 300 women (150 Premenopausal & 150 Postmenopausal) in our study. Fasting blood glucose, lipid profile, blood pressure and relevant adiposity indices (BMI, WC, WHR, WHtR &VAI) were determined using standard protocols. To analyze the correlation of WC,WHR, WHtR, BMI and VAI with MS Spearmann test was used. Results: Metabolic syndrome was presented in 61.58% respondents and it was more prevalent among postmenopausal (69.09 %) as compared to premenopausal (51.25 %) women. Prevalence of high blood pressure, elevated fasting blood glucose, and high triglyceride were significantly higher in postmenopausal women than premenopausal women. However, prevalence of low high-density lipoprotein cholesterol was significantly lower in postmenopausal women than premenopausal women. Conclusion: In our study we found a high prevalence of MS in post-menopausal women which was significantly higher than pre-menopausal women. Low HDL cholesterol, elevated fasting blood glucose, and high blood pressures were the most frequent features in comparison to the others.

A incontinência urinária nas fases de climatério e menopausa: Efeitos, Consequências e Aceitação / Urinary incontinence in the climacteric and menopause phases: Effects, Consequences and Acceptance

Este trabalho traz a reflexão, através de conhecimentos multidisciplinares, sobre a incontinência urinária em decorrência da menopausa. Conceitua, a critério de informação, as diferentes fases que compõem o período de finalização da menstruação, experenciadas pelo público feminino, mais especificamente o climatério, pré-menopausa, menopausa e pós-menopausa. A discussão tem o objetivo de encontrar alternativas de comunicação e interação com a mulher em menopausa e trabalhar todos os sintomas possíveis encontrados nesta fase da vida, para que ela perceba a importância e a necessidade de procurar ajuda médica, informações inerentes ao tema, para uma melhor qualidade de vida, saúde e segurança nas suas transformações físicas e psíquicas. Reflete-se também sobre a realidade da mulher, os efeitos e impactos da menopausa na vida dela e a incontinência urinária como efeito dessa passagem. Como elas enfrentam essa condição no dia a dia e a insegurança que carregam ao viverem esse momento de transformação e 'perdas' relacionadas. Por isso, os profissionais debatem sobre a importância da comunicação e da disseminação da informação como caminhos para auxiliar na compreensão desse público a tudo relacionado à condição de incontinência urinária, em especial na menopausa. Os temas também debatem sobre a rede de apoio e o papel de cada um na percepção das mulheres ao que elas devem fazer, como fazer e por que fazer os tratamentos preventivos ou remediativos. É ciclo natural da vivência da mulher, mas os sintomas e efeitos não podem ser naturalizados, por isso a necessidade de se entender o panorama da incontinência urinária, nível Brasil, na vida das mulheres em menopausa.(AU)

This work brings reflection, through multidisciplinary knowledge, on urinary incontinence due to menopause. It conceptualizes, at the discretion of information, the different phases that make up the period of completion of menstruation, experienced by the female public, more specifically the climacteric, pre-menopause, menopause and post-menopause. The purpose of the discussion is to find alternatives for communication and interaction with women undergoing menopause and to work on all the possible symptoms found in this phase of life, so that she realizes the importance and need to seek medical help, information inherent to the subject, for a better quality of life, health and safety in their physical and mental transformations. It also reflects on the reality of women, the effects and impacts of menopause on her life and urinary incontinence as an effect of this transition. How they face this condition on a daily basis and the insecurity they carry when experiencing this moment of transformation and related 'losses'. Therefore, professionals discuss the importance of communication and dissemination of information as ways to help this public understand everything related to the condition of urinary incontinence, especially in menopause. The themes also discuss the support network and the role of each one in the women's perception of what they should do, how to do it and why to do preventive or remedial treatments. It is a natural cycle of women's experience, but the symptoms and effects cannot be naturalized, hence the need to understand the panorama of urinary incontinence, at the level of Brazil, in the lives of women undergoing menopause.(AU)

Este trabajo trae la reflexión, a través del conocimiento multidisciplinario, sobre la incontinencia urinaria por menopausia. Conceptualiza, a criterio de la información, las diferentes fases que componen el período de finalización de la menstruación, experimentado por el público femenino, más específicamente el climaterio, la premenopausia, la menopausia y la posmenopausia. El propósito de la charla es encontrar alternativas de comunicación e interacción con la mujer en la menopausia y trabajar todos los síntomas posibles encontrados en esta etapa de la vida, para que ella se dé cuenta de la importancia y necesidad de buscar ayuda médica, información inherente al tema. , para una mejor calidad de vida, salud y seguridad en sus transformaciones físicas y mentales. También reflexiona sobre la realidad de la mujer, los efectos e impactos de la menopausia en su vida y la incontinencia urinaria como efecto de esta transición. Cómo enfrentan esta condición en el día a día y la inseguridad que cargan al vivir este momento de transformación y las 'pérdidas' relacionadas. Por lo tanto, los profesionales discuten la importancia de la comunicación y la difusión de información como formas de ayudar a este público a comprender todo lo relacionado con la condición de incontinencia urinaria, especialmente en la menopausia. Los temas también discuten la red de apoyo y el papel de cada uno en la percepción de las mujeres sobre lo que deben hacer, cómo hacerlo y por qué hacer tratamientos preventivos o curativos. Es un ciclo natural de la experiencia de la mujer, pero los síntomas y los efectos no se pueden naturalizar, de ahí la necesidad de comprender el panorama de la incontinencia urinaria, a nivel de Brasil, en la vida de las mujeres en fase de menopausia.(AU)

Sociodemographic characteristics associated with indications for surgical menopause in women: a retrospective study

SUMMARY OBJECTIVE: The aim of this study was to evaluate the surgical menopause indications and sociodemographic characteristics of women. METHODS: In this retrospective study, we analyzed the sociodemographic characteristics of women with indications for surgical menopause in 2010-2020. The R Version 4.1.1 (2021-08-10) software and logistic regression analysis were used to evaluate the data. RESULTS: A total of 704 women's data were obtained in this study. Surgical menopause indications were found to stem from bleeding (46.0%), cancer (28.3%), cancer risk (18.9%), and other causes (6.8%). Surgical menopause indications originating from cancer were increased by 0.08 times (95%CI 0.01-0.68) due to smoking, 0.45 times (95%CI 0.23-0.88) due to regular drug use, and 0.36 times (95%CI 0.19-0.69) due to the presence of chronic disease (p<0.05). CONCLUSION: More than half of the women with surgical menopause indications were between 41 and 46 years of age. Additionally, 54.9% of the women had a chronic disease. Therefore, it is recommended to plan preventive health services for morbidity and mortality risks that may develop due to surgical menopause.

Luto e desejo na menopausa: contribuições psicanalíticas / Grief and desire in menopause: psychoanalytic contributions / Deuil et désir à la ménopause: apports psychanalytiques / Duelo y melancolia en la menopausia: aportes psicoanalíticos

Menopausa é o termo indicado pela OMS para nomear o último ciclo biológico da mulher, em que há o encerramento da capacidade reprodutiva feminina. Notando que o tema da menopausa parece despertar pouco interesse nas esferas social e científica e foi conotado negativamente pela teoria psicanalítica por um período, o objetivo deste artigo é traçar algumas considerações da psicanálise, partindo de Freud e Lacan, acerca do fenômeno. Para tal, utiliza-se o conceito de luto como operador teórico para reflexão do tema e enlaçamento com a teoria, passando por falas de mulheres menopáusicas. Considera-se, neste artigo, que o real da menopausa pode encontrar um caminho de tratamento que passe pelo luto e pelo simbólico, chegando ao desejo — colocando, assim, outras contribuições psicanalíticas a respeito do tema.

Resumos Menopause is the term indicated by the WHO to name the last biological cycle of the woman, in which there is the end of the female reproductive capacity. Noting that the topic of menopause seems to arouse little interest in the social and scientific spheres and was negatively connoted by psychoanalytic theory for a period, the purpose of this article is to outline some considerations of psychoanalysis, starting from Freud and Lacan, about the phenomenon. To this end, the concept of mourning is used as a theoretical operator to reflect on the theme and link it with the theory, passing through the speeches of menopausal women. It is considered, in this article, that the real of menopause can find a way of treatment that passes through mourning and the symbolic, reaching desire - thus placing other psychoanalytic contributions on the subject.

La ménopause est le terme indiqué par l'OMS pour nommer le dernier cycle biologique des femmes, dans lequel il y a la fin de la capacité reproductive féminine. Constatant que le thème de la ménopause semble susciter peu d'intérêt dans les sphères sociales et scientifiques et qu'il a été connoté négativement par la théorie psychanalytique, cet article retrace quelques considérations psychanalytique, basées sur Freud et Lacan, sur le phénomène. Pour ce faire, on utilise le concept de deuil comme opérateur théorique pour réfléchir au thème et le relier à la théorie, à travers les discours des femmes ménopausées. Il considère que le réel de la ménopause peut trouver une voie de traitement qui passe par le deuil et le symbolique, pour atteindre le désir — plaçant ainsi d'autres apports psychanalytiques sur le sujet.

La menopausia es el término que utiliza la Organización Mundial de la Salud (OMS) para denominar el último ciclo biológico de la mujer, en el que se produce el final de la capacidad reproductiva femenina. A partir de las observaciones de que el tema de la menopausia parece despertar poco interés en las esferas social y científica, y que fue connotado de manera negativa por la teoría psicoanalítica durante un período, el propósito de este artículo es esbozar algunas consideraciones del psicoanálisis, a partir de Freud y Lacan, sobre el fenómeno. Para ello, se utiliza el concepto de duelo como operador teórico para reflexionar sobre el tema y vincularlo con la teoría, pasando por los discursos de las mujeres menopáusicas. Se considera, en este artículo, que lo real de la menopausia puede encontrar una vía de tratamiento que pasa por el duelo y lo simbólico, y alcanza el deseo, logrando así otros aportes psicoanalíticos al tema.